Xiamen HeroSheng Corporation Group – Trademark Portfolio

Entity Type: 03

Xiamen HeroSheng Corporation Group holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HEROSHENG. The owner is based in Xiamen City, Fujian,.

Room 1505, NO.16 Taoyuan Road,

Xiamen City, Fujian, 361008 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Xiamen HeroSheng Corporation Group's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Xiamen HeroSheng Corporation Group have?

Xiamen HeroSheng Corporation Group has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Xiamen HeroSheng Corporation Group file in?

Xiamen HeroSheng Corporation Group files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.

What are Xiamen HeroSheng Corporation Group's most well-known trademarks?

Xiamen HeroSheng Corporation Group's registered trademark portfolio includes well-known marks such as HEROSHENG. These are among 2 currently registered trademarks in the portfolio.

What is Xiamen HeroSheng Corporation Group's trademark registration success rate?

Xiamen HeroSheng Corporation Group has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.